Filing Details
- Accession Number:
- 0000921895-19-002367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-05 16:37:12
- Reporting Period:
- 2019-09-03
- Accepted Time:
- 2019-09-05 16:37:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1114916 | Balaji Venkataraman | 1055B Powers Place Alpharetta GA 30009 | No | No | Yes | Yes | |
| 1772491 | Altiva Management Inc. | 1055B Powers Place Alpharetta GA 30009 | No | No | Yes | Yes | |
| 1785731 | Velan Capital, L.p. | 1055 Powers Place, Suite B Alpharetta GA 30009 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0013 Par Value | Acquisiton | 2019-09-03 | 277,424 | $4.39 | 7,696,096 | No | 4 | P | Direct | |
| Common Stock, $0.0013 Par Value | Acquisiton | 2019-09-04 | 243,614 | $4.51 | 7,939,710 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This Form 4 is filed jointly by Velan Capital, L.P. ("Velan Capital"), Altiva Management Inc. ("Altiva"), and Balaji Venkataraman (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 1(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
- Securities owned directly by Velan Capital. Each of Altiva, as the general partner of Velan Capital, and Mr. Venkataraman, as the sole shareholder of Altiva, may be deemed to beneficially own the securities owned directly by Velan Capital.
Billionaire Hedge Funds
